ATRS - Antares Pharma News - Barchart.com Antares Pharma (ATRS) Antares Pharma (ATRS) [[ item.lastPrice ]] Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener. Barchart Trade Picks. ATRS Stock Price Quote & News - Antares Pharma | Robinhood View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought like VKTX, AMRN, PLUG, and ACB. 3,704 people own Antares Pharma on Robinhood on April 4, 2020. Why Antares Pharma's Sliding 10% Today | The Motley Fool Overall, revenue was up 92% year over year, to $34.3 million in the third quarter of 2019, which resulted in net income of $1 million, or $0.01 per share. Antares Pharma, Inc. - TheStreet
ATRS | Expert Financial Analysis and Reporting | Smith on ...
Penny Stocks Post Tag - ATRS - Penny Stocks to Buy, Picks ... May 02, 2019 · Penny Stocks (PennyStocks.com) is the top online destination for all things Micro-Cap Stocks. On PennyStocks.com you will find a comprehensive list of Penny Stocks & discover the best Penny Stocks to buy, top penny stock news and micro-cap stock articles. 2020 is expected to be a huge year for penny stocks. ATRS, Antares Pharma Inc - Stock Investment Research, IBD ... Nov 01, 2019 · TODAY'S SPOTLIGHT Stock Market Survival Guide . Get tips on protecting your retirement, shorting stocks and preparing for the next bull market! 30-Second Flash Sale! You have 30 seconds to save $60 on IBD Digital + Print. April Fool's! This deal lasts 24 hours. All-New Podcast Episode . When can we hope for a stock market rebound? ATRS.O - Antares Pharma Inc Profile | Reuters Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The
Antares Pharma Inc. - NASDAQ:ATRS - Stock Quote & News ...
Why Antares Pharma's Sliding 10% Today | The Motley Fool Overall, revenue was up 92% year over year, to $34.3 million in the third quarter of 2019, which resulted in net income of $1 million, or $0.01 per share. Antares Pharma, Inc. - TheStreet
ATRS Stock | ANTARES PHARMA Stock Price Today | Markets ...
Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The ATRS -- Is Its Stock Price A Worthy Investment? Learn More. ATRS Stock Summary. With a year-over-year growth in debt of 87.4%, Antares Pharma Inc's debt growth rate surpasses 84.66% of about US stocks. Over the past twelve months, ATRS has reported earnings growth of -139.64%, putting it ahead of merely 10.44% of US stocks in our set. ATRS:Vienna Stock Quote - Atrium European Real Estate Ltd ... Stock analysis for Atrium European Real Estate Ltd (ATRS:Vienna) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma Inc ATRS - Quotes, Financials, News, Charts ... Stocks Rankings for ATRS. U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right
Real time Antares Pharma (ATRS) stock price quote, stock graph, news Why Nielsen Holdings, Diebold Nixdorf, and Antares Pharma Jumped Today.
ATRS Stock Quote - Antares Pharma, Inc. Common Stock Price ...